Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Amgen stock opened at $314.38 on Friday. The company has a debt-to-equity ratio of 9.62, a current ratio of 1.26 and a quick ratio of 0.95. The firm has a market capitalization of $168.89 billion ...

Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best biotech stocks. Although biotech stocks had a “challenging” year in 2024, JPMorgan ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other AI stocks. In a recent discussion at CNBC's 'Squawk on the Street', NYU professor and AI ...

Amgen Inc.'s stock has surged 13% recently, likely due to promising developments with its obesity injection, MariTide, which offers unique benefits over current treatments. MariTide's dual ...

Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options history for Amgen AMGN revealed 19 unusual trades. Delving into the details, we found 26% of traders were ...